Abstract Details

Title Clinical Trial Simulations for Paediatric Dose Selection Using a Pharmacokinetic/Enzyme-Occupancy/Pharmacodynamic Model of TAK-935, a Cholesterol 24S-hydroxylase Inhibitor

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) P5 - (-)

Poster/Presentation
Number 265

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
Asif M. Paker, MD, MPH	Dr. Paker has received personal compensation for serving as an employee of SwanBio Therapeutics.
	No disclosure on file
	No disclosure on file
	No disclosure on file